ABSTRACT. Through observations of colloidal gold with silver enhancement, we have demonstrated that 2-nm colloidal gold labeled-testosterone-bovine serum albumin (BSA) conjugate or hydrocortisone-BSA conjugate injected intravenously enters the hormone-target cell nuclei of rats (Nishimura and Ichihara, 1997; Nakano, 1997, 1999). To confirm immunocytochemically whether the nature of BSA in the steroid hormone-BSA conjugates (steroid-BSAs) remains intact in the hormone-target cell nuclei, testosterone-BSA, hydrocortisone-BSA or corticosterone-BSA was injected into the vascular system of rats, then the liver and testes of rats killed 2 h postinjection were reacted with FITC-conjugated anti-BSA antibody, and examined under fluorescence microscopy and confocal laser scanning microscopy. In the liver of rat injected with testosterone-BSA, the fluorescence was observed in the nuclei of endothelial cells, but not in the nuclei of hepatocytes, hepatic stellate cells and Kupffer cells. In the liver of rat injected with hydrocortisone-BSA, intense fluorescence was seen in the nuclei of hepatic stellate cells, but did not seem to be present in the nuclei of the other three kinds of cells. In the liver of rat injected with corticosterone-BSA, the fluorescence seemed to be in a few nuclei of hepatic stellate cells, and appeared as speckles in a few nuclei of the hepatocytes and Kupffer cells. In some seminiferous tubules of rat injected with testosterone-BSA, fluorescence was observed in the nuclei of spermatocytes and spermatids. These results suggest that BSA conjugated with steroid hormone can enter the hormone-target cell nuclei with its antigenicity kept intact, and that the fate of steroid-BSAs is decided at the cell membrane level.
Steroid hormones circulate in blood plasma in three physical states: free, albumin-bound, and bound to serum steroid binding proteins such as sex hormone-binding globulin (SHBG) and corticosteroid-binding globulin (CBG) (Kuhn, 1988; Pardridge, 1988; Pescovitz et al., 1990; Rosner et al., 1988) . Radiolabeled steroid hormones, e.g., [ 3 H]-testosterone, [ 3 H]-hydrocortisone and [
3 H]-corticosterone, may enter the target cell nuclei in vivo (Beato et al., 1969; Csaba et al., 1970; Csaba and Fülöp, 1987; Murtazaeva et al., 1978; Sar et al., 1970 Sar et al., , 1975 . In the classic, or genomic model of steroid hormones, free lipophilic nonproteinbound hormones cross the cell membrane under passive transport to bind to the receptor in the cytoplasm, and the hormone-receptor complex is translocated into the target cell nucleus to exert genomic effects (Bamberger et al., 1996; Guiochon-Mantel et al., 1996; Htun et al., 1996; Jensen and DeSombre, 1972; Madan and DeFranco, 1993; Mangelsdorf et al., 1995; Mendel, 1992 ). In contrast, steroid hormones conjugated with radioiodinated-or fluorescein-isothiocyanate (FITC)-labeled-bovine serum albumin (BSA) have been used in analyzing the binding sites of steroid hormones to cell membranes (Bergqvist et al., 1984; Ke and Ramirez, 1990; Pertschuk et al., 1980; Rao et al., 1980) , because steroids coupled with highmolecular weight substances cannot pass through the cell membrane and do not enter the cytosol. Thus, steroids coupled with high-molecular weight substances, e.g. steroid hormone-BSA conjugates (steroid-BSAs), are also used to study the membrane-initiated or nongenomic activities of steroid hormones (Duval et al., 1983; Gametchu et al., 1999; Revelli et al., 1998; Rosner et al., 1999; Rossato et al., 1999; Wehling, 1997) . Pietras and Szego (1984) have suggested that endocytotic vesicles serve as vehicles for the nuclear transfer of steroid hormones (Szego, 1984) . Radiolabeled testosterone coupled with SHBG or androgen-binding protein is internalized by receptor-mediated endocytosis in spermatogenic cells, and then enters these cell nuclei in vitro (Gerard et al., 1991; Gerard, 1995; Gerard et al., 1994) . CBG is also detected within the hormone-target cell nuclei (Kuhn, 1988; Rosner et al., 1988; Selcer and Leavitt, 1988) . Gold labeled-steroid-BSA binds to nuclear receptors in the sectioned cells (Beppu, 1989; Okuda et al., 1989) . We have reported that 2-nm colloidal gold labeled-testosterone-BSA (testosterone-BSAgold) and gold labeled-hydrocortisone-BSA (hydrocortisone-BSA-gold) injected into rats enters the hormone-target cell nuclei (Nishimura and Ichihara, 1997; Nakano, 1997, 1999) , and have also demonstrated the possibility that testosterone-BSA-gold taken up in the vesicle by receptor-mediated endocytosis can enter the nucleoplasm through the fusion of the vesicle membrane with the partial diaphragm in the nuclear envelope, without coming in direct contact with the cytosol (Nishimura and Nakano, 1997) . A wide variety of macromolecules taken up by endocytosis are incorporated by lysosomes, or the Golgi apparatus, or both (Alberts et al., 1994; Claus et al., 1998; Olkkonen and Stenmark, 1997; Rothman and Wieland, 1996) . Colloidal gold as a marker of BSA seems to be stable in the lysosome (Bright et al., 1997; Fengsrud et al., 1995; Yoshioka et al., 1994) . Therefore, it is unclear whether or not the nature of BSA in testosterone-BSA-gold and hydrocortisone-BSAgold is maintained in the nucleus.
The nuclear concentration of testosterone-BSA-gold was observed mainly in spermatogenic cells, with few in hepatocytes (Nishimura and Ichihara, 1997) , as reported in studies using radiolabeled testosterone (Sar et al., 1970 (Sar et al., , 1975 . In contrast nuclear localization of hydrocortisone-BSA-gold was done in hepatocytes and hepatic stellate cells (Nishimura and Nakano, 1999) . In control, there was little nuclear localization of colloidal gold labeled-BSA in these cells (Nishimura and Ichihara, 1997) . Since hydrocortisone is not synthesized in rats, corticosterone acts as a glucocorticoid (Pescovitz et al., 1990) . In the present study, we attempted to detect immunocytochemically the location of BSA in the liver and the testis of rats injected with no gold labeledtestosterone-BSA, hydrocortisone-BSA or corticosterone-BSA conjugate (corticosterone-BSA), by using the antibody against the BSA.
Materials and Methods

Materials
Testosterone-3-o-carboxymethyloxime-bovine serum albumin conjugate (29 mols steroid per mole albumin, testosterone-BSA), hydrocortisone 21-hemisuccinate-bovine serum albumin conjugate (21 mols steroid per mole albumin, hydrocortisone-BSA) and corticosterone 21-hemisuccinate-bovine serum albumin conjugate (23 mols steroid per mole albumin, corticosterone-BSA) were purchased from Sigma (St. Louis, MO, USA). Anti-bovine serum albumin rabbit serum (anti-BSA serum) was purchased from Biogenesis (Poole, England). FITC-conjugated rabbit anti-bovine serum albumin antibody (anti-BSA antibody-FITC) was purchased from Inter-Cell Technologies, Inc. (Hopewell, NJ, USA).
Pretreatment of antibody
To get the normal rat liver-and testis-powder, livers and testes removed from normal rats were homogenized and freeze-dried. Anti-BSA antibody-FITC of 0.5 ml was stirred with 20 mg of normal rat liver-or testis-powder for 1 h at freezing temperature, then centrifuged at 10,000 g for 1 h at 4°C. The supernatants were used as the antibody for the liver or testis, respectively.
Administration of testosterone-BSA to rat
Testosterone-BSA was dissolved at 1 mg/ml in saline with 5% glycerol. Hydrocortisone-BSA or corticosterone-BSA was dissolved at 2 mg/ml in saline with 5% glycerol. Rats (Wistar strain, male, 10 weeks old) were injected with 1 ml testosterone-BSA, 1 ml hydrocortisone-BSA or 1 ml corticosterone-BSA through the tail vein under ether anesthesia. After 2 h, the rats were perfused with 30 ml of saline, and then fixed by perfusion of paraformaldehyde fixative (4% paraformaldehyde in 0.1 M phosphate buffer, pH 7.4) for 10 min from the left to the right ventricle under ether anesthesia. The liver and testis were removed, cut into approximately 5-mm blocks and immersed in the same fixative for 2 h. The tissue blocks were washed with phosphate buffer, then immersed in phosphate buffer containing 15% sucrose overnight at 4°C. The tissue blocks were frozen rapidly in liquid nitrogen, kept at -80°C, then sliced to a thickness of 5-mm.
Control experiment
The control rat, which received no injections, was fixed by perfusion as above. The liver and testis were removed, cut into pieces, fixed, and sectioned as above.
Immunofluorescence staining
The tissue sections were fixed with methanol for 20 min, dried, and washed with Dulbecco's phosphate-buffered saline (PBS -), for 5 min. Sections were reacted with normal rabbit serum for 30 min, then with the antibody for liver or testis for 2 h at room temperature, and washed with PBS -for 5 min. The washing was repeated four times. Sections were stained with 0.01% Evans blue in PBS -for 5 min, washed with PBS -for 5 min, and coverslides were mounted with PermaFluor Aqueous Mounting Medium (Shandon, Pittsburgh, PA, USA) for observation. Fluorescence images were obtained with a fluorescence microscope (Olympus, Tokyo, Japan) and a confocal laser scanning microscope (LSM-GB200: Olym-pus, Tokyo, Japan; LSM).
Results
It was first confirmed that anti-BSA serum reacted with testosterone-BSA, hydrocortisone-BSA, corticosterone-BSA and bovine serum, but not with rat serum, by Ouchterlony double-diffusion analysis (data not shown).
In the testis of the rat sacrificed 2 h after injection of testosterone-BSA, FITC fluorescence implying the presence of testosterone-BSA was observed in the locations of spermatocytes and spermatids in some seminiferous tubules (Fig. 1a) . When the testis was observed under the LSM, the fluorescence was detected as being in the nuclei of the spermatocytes and the spermatids (Fig. 1b) . In the liver, no fluorescence was observed in the nuclei of hepatocytes, hepatic stellate cells, or Kupffer cells. However, a few cells on the sinusoidal wall showed intense fluorescence under the fluorescence microscope (Fig. 2a) . In some hepatocytes, the fluorescence was observed as many granules in the cytoplasm (Fig. 2b) . Under the LSM, the fluorescence was detected as being in the nuclei of endothelial cells (Fig. 2c) .
In the liver of the rat sacrificed 2 h after injection of hydrocortisone-BSA, intense fluorescence was seen in the nonparenchymal cells (Fig. 3a) , and faint fluorescence in the hepatocytes, under the fluorescence microscope. Under the LSM, the intense fluorescence was found to be in the nuclei (Fig. 3b, c) and vesicles, or on the invaginated cell membrane (Fig. 3c) of hepatic stellate cells. The fluorescence in these nuclei was the most intense among all the cell nuclei examined in this study. No clear fluorescence was detected in the nuclei of endothelial cells (Fig. 3c) . In the hepatocytes, fluorescence was also observed faintly in the cytoplasm and on the cell surface (Fig. 3c) , but did not seem to be in the nucleus (Fig, 3b, c) . In a very few Kupffer cells, faint fluorescence was detected in the cytoplasm, but did not seem to be in the nucleus (data not shown).
In the liver of rat sacrificed 2 h after injection of corticosterone-BSA, intense fluorescence was observed in some hepatocytes and nonparenchymal cells under fluorescence microscopy (Fig. 4a) . However, the fluorescence in the nonparenchymal cells appeared weaker than that in the nuclei of the hepatic stellate cells of the rat injected with hydrocortisone-BSA. Under the LSM, intense fluorescence was observed as various granules in the cytoplasm of many cells, and as speckles in a few of the nuclei of hepatocytes (Fig. 4b) . The fluorescence in the cytoplasm of the hepatocytes was more intense than that in rat injected with hydrocortisone-BSA. The immunostaining of nonparenchymal cells was divided into two patterns. In one, the fluorescence was found mainly in the cytoplasm and as speckles in a few nuclei (Fig. 4c) . In the other, it was diffuse in the nucleus, but rare or nonexistent in the cytoplasm (Fig.  4d) . The former pattern was detected in what appeared to be Kupffer cells, and the latter in hepatic stellate cells.
When the liver or the testis of the control rat, which received no injections, was reacted with the antibody for liver or for testis, no fluorescence was observed in the liver (not shown) or the cells in the seminiferous tubules (Fig. 1c) under either fluorescence or LSM-GB200 microscope.
Discussion
In previous studies in which testosterone-BSA-gold was injected into rats, silver deposits implying the presence of testosterone-BSA-gold were abundantly observed in the nuclei of spermatocytes and round spermatids in the target cells with silver enhancement (Nishimura and Ichihara, 1997; Nishimura and Nakano, 1997) . The present study confirms the results of these previous studies, and suggests that testosterone-BSA enters the nuclei of spematocytes and spermatids with the antigenicity of BSA kept intact. However, further study is needed as to whether the antigenicity of BSA remains in other testosterone-target cells, e.g. spermatogonia, of the testis. Glucocorticoid receptors were detected in the nuclei of spermatocytes of rats (Schultz et al., 1993) . Direct immunofluorescence in this study, however, did not reveal intense fluorescence in the spermatocyte nuclei of rats injected with hydrocortisone-BSA or corticosterone-BSA. Further study is need to determine whether or not hydrocortisone-BSA and corticosterone-BSA enter the spermatocyte nuclei.
Chemically modified serum albumin, such as formaldehyde-denatured albumin (FDA), is rapidly cleared from the bloodstream (Takami et al., 1992) . The organ responsible for this is the liver. FDA is internalized by liver sinusoidal cells, such as Kupffer cells and endothelial cells, through a receptor-mediated endocytosis and is delivered to the lysosomal compartment (Mego et al., 1967; Nilsson and Berg, 1977; Yokota and Fahimi, 1987; Yoshioka et al., 1994) . By contrast, normal serum albumin injected intravenously persists in the bloodstream of different animals for prolonged periods of time (Long et al., 1963; Owen et al., 1975) . The nonparenchymal liver cells and endothelial cells of mouse liver do not take up injected BSA (Hope et al., 1981; Kosugi et al., 1992) . In the present study, the results for the Kupffer cells of the rat injected with testosterone-BSA are compatible with our previous studies, in which little testosterone-BSA-gold was taken up by macrophages (Nishimura and Ichihara, 1997) . Kupffer and endothelial cells have been shown to be devoid of immunoreactivity for glucocorticoid receptors in histological sections of rat liver (Antakly and Eisen, 1984) , whereas, the present study shows that corticosterone-BSA enters the Kupffer cell nuclei. This result is compatible with a report that glucocorticoid receptor is present in the nuclei of isolated Kupffer cells (Raddatz et al., 1996) , but incompatible with the result for hydrocortisone-BSA in the present study. Furthermore, this study shows that testosterone-BSA is incorporated in the endothelial cell nuclei. This result is supported by the reports that endothelial cells exhibit immunoreactivity for androgen receptors (Bläuer et al., 1991; Kimura et al., 1993; Liang et al., 1993) . In this study, however, we failed to detect the intense fluorescence of hydrocortisone-BSA or corticosterone-BSA in endothelial cell nuclei that would indicate immunoreactivity for glucocorticoid receptors (Karstila et al., 1994) . Though it is unclear whether Kupffer and endothelial cells take up the administered steroid-BSAs as steroid hormone, denaturated BSA or both, the existence of BSA in these cell nuclei indicates that these cells may recognize the steroid-BSAs as hormone, and it is possible that there is some mechanism that disturbs the digestion of steroid-BSAs by lysosomal enzymes. Estrogen is likely to decrease acidification of the early endosomes (Gay et al., 1993; Van Dyke and Root, 1993) .
A synthetic glucocorticoid, dexamethasone, affects the gene expression of hepatic stellate cells isolated from rat liver (Ramadori et al., 1991) . Hepatic stellate cell nuclei exhibit immunoreactivity for glucocorticoid receptors (Raddatz et al., 1996) . This study confirms our previous report that the percentage of nuclei showing silver deposits, implying the presence of hydrocortisone-BSA-gold, was highest in hepatic stellate cells in rats injected with hydrocortisone-BSA-gold, and demonstrates that hydrocortisone-BSA enters the nuclei of the hepatic stellate cells with the antigenicity of BSA kept intact.
The liver is an organ of steroid hormone metabolism (Horton, 1990; Pescovitz et al., 1990) . This study confirms our previous report that testosterone-BSA-gold is incorporated mainly in the cytoplasm of hepatocytes, with few in their nuclei (Nishimura and Ichihara, 1997) . Serum proteins can be taken up by fluid-phase or receptor-mediated endocytosis by hepatocytes, and then recycled back to the basolateral membrane, degraded in lysosomes, or directed to bile (Crawford, 1996) . In rat hepatocytes, radiolabeled BSA is taken up by fluid-phase endocytosis (Strømhaug et al., 1997) , and the BSA injected intravenously is delivered into bile (Limet et al., 1985) . Isolated rat hepatocytes also incorporate gold labeled-BSA in their lysosomes (Fengsrud et al., 1995) . In contrast, this study shows that corticosterone-BSA is found in the nuclei of hepatocytes. This result is supported by reports that there are glucocorticoid receptors in the hepatocyte nucleus (Antakly and Eisen, 1984; Raddatz et al., 1996) , that radioactivity of [ 3 H]-corticosterone is observed in the hepatocyte nucleus (Murtazaeva et al., 1978) , and that the nuclear receptors in rat liver are specific for glucocorticoids, not testosterone (Shaskas and Bottoms, 1974) . In this study, however, we failed to detect antigenicity of BSA conjugated with hydrocortisone in the hepatocyte nuclei. This result is incompatible with a previous report that hydrocortisone-BSA-gold enters the hepatocyte nuclei (Nishimura and Nakano, 1999) . In the rat liver cell membrane, corticosterone exhibits higher binding affinity than hydrocortisone in competition experiments (Suyemitsu and Terayama, 1975; Truebe et al., 1991) . The administration of estrogen to rats results in the intranuclear accumulation of lysosomal enzymes in steroid target cells such as cells of the preputial gland (Szego et al., 1974) . Markers of BSA such as gold seem to be more stable during intracellular digestion than BSA. Intense fluorescence of hydrocortisone-BSA is observed in the nuclei of hepatic stellate cells, in which lysosomes are either very few or absent (Wake, 1980) . Further study is needed to determine whether hydrocortisoneprotein conjugate enters the nuclei of the hepatocytes with its antigenicity kept intact.
Glucocorticoid receptor immunoreactive sites are associated with the plasma membrane and coated and regular vesicles in hippocampal and hypothalamic neurons of rat (Liposits and Bohn, 1993) . Estrogen receptor-=tends to be found on the cell membrane of rat pituitary tumor cells . The present study also shows that the three kinds of steroid-BSAs exhibit different distributions in hepatocytes, Kupffer cells, hepatic stellate cells and endothelial cells. The observed distribution in the liver indicates that these four kinds of cells can distinguish between the difference in the three kinds of steroid-BSAs at the cell membrane level.
As stated above, this study suggests that a protein conjugated with steroid hormone retains its antigenicity in the target cell nuclei. A DNA virus, simian virus 40 (SV40), enters the nucleus by vesicle-mediated traffic (Nishimura et al., 1991) and maintains its original size (Hummeler et al., 1970) . Testosterone-BSA-gold enters the spermatid nucleus by a mechanism similar to that of SV40 (Nishimura and Nakano, 1997) . The author considers that the vesicular trafficking from the extracellular milieu into the nucleus may play an important role in the processes of evolution. The next step is to confirm whether steroid hormones serve as a carrier to transport DNA into the nuclei of target cells, e.g. spermatogenic cells.
